Dr. Tucker is a board certified pharmacotherapy and infectious diseases specialist with a master’s degree in healthcare informatics. Prior to joining Wilkes, he completed 2-year infectious diseases, epidemiology & outcomes research fellowship at Oregon State University & Oregon Health & Science University. Dr. Tucker completed PGY1 residency at the University of New Mexico Hospital and a PGY2 residency in infectious diseases at Novant Health Forsyth Medical Center in Winston-Salem and graduated from pharmacy school at the South Carolina College of Pharmacy, University of South Carolina campus. Dr. Tucker’s academic and clinical interests include antimicrobial stewardship, clinical decision support, quality improvement metrics and implementation science.
Infectious Disease Epidemiology & Outcomes Research Fellowship, Oregon State/ Oregon Health & Science Universities, 2019-2021
Human Investigations Certificate Program, Oregon Health & Science University, 2019-2021
PGY-2 Infectious Disease Pharmacy Residency, Novant Health Forsyth Medical Center, 2018-2019
PGY-1 Pharmacy Practice Residency, University of New Mexico Hospital, 2017-2018
Doctor of Pharmacy, South Carolina College of Pharmacy/University of South Carolina, 2013-2017
Master of Health Information Technology, University of South Carolina, 2015-2017
Tom FS, Tucker KJ, McCracken CM, McGregor JC, Gore SJ. Infectious complications of probiotic use: a matched case-control study. Infect. Control Hosp. Epidemiol. Jul 2021.
Rivera CG, Mehta M, Ryan KR, Stevens RW, Tucker KJ, Mahoney MV. Role of infectious diseases pharmacists in outpatient intravenous and complex oral antimicrobial therapy: Society of Infectious Diseases Pharmacists insights. JACCP. May 2021.
Ham YY, Joshi S, Sukerman E, Tucker KJ, Yu D, Lewis JS. Safety and efficacy of direct 2-step challenges with an inpatient pharmacist-driven allergy evaluation. Allergy Asthma Proc. Mar 2021.
Tucker KJ, Ham YY, Holmer HK, McCracken CM, Lewis JS, McGregor JC. Assessment of beta-lactam allergies as rationale for receipt of vancomycin for surgical prophylaxis. IDWeek 2020. Virtual meeting. October 21st-25th, 2020. [Abstract] Open Forum Infect Dis. Dec 2020
Ray MJ, McCracken CM, Tucker KJ, Yu D, Underwood M, Wu E, Kastelic K, Nolt D, McGregor JC. Evaluating appropriateness of antibiotic prescribing in pediatric inpatients. IDWeek 2020. Virtual meeting. October 21st-25th, 2020. [Abstract] Open Forum Infect Dis. Dec 2020
Tucker KJ, Benning M, Walraven C, Ryan K, Jakeman B. A single-center evaluation of extended infusion piperacillin/tazobactam for empiric treatment in the intensive care unit. J Pharm Tech. Aug 2020.
Gore SJ, Tucker KJ, Strasfeld LM, McGregor JC. Bloodstream Infections with Typical Probiotic Organisms. 6th Decennial International Conference on Healthcare Associated Infections.
[Oral Presentation] Atlanta, GA. March 29, 2020.
Mediwala K, Kohn J, Bookstaver P.B, Justo J.A, Rac H, Tucker KJ, Lashkova L, Al-Hasan M.N.
Syndrome-Specific versus Prospective Audit and Feedback Interventions for Reducing Utilization of Broad-Spectrum Antimicrobial Agents. Am. J. infect. Control. Jun 2019.
Tucker KJ, Chin J, Gould A. Impact of respiratory panel detection of virus on antimicrobial de-escalation in a multi-hospital system MAD-ID 2019, Orlando, FL. May 8th-11th, 2019.
Tucker KJ, Benning M, Walraven C, Ryan K, Jakeman B. Appropriateness of empiric extended infusion piperacillin/tazobactam in the Intensive Care Unit IDweek, San Francisco CA. October 3rd-7th, 2018.
Tucker KJ, Lashkova L, Fleming T, Justo J. A, Kohn J. Al-Hasan M.N, Sanasi K. Bookstaver P.B Results of a Stewardship initiative to address carbapenem over-utilization at a multi-hospital system. Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego CA. September 17th-21st, 2015.
Website committee Vice Chair – Society of Infectious Disease Pharmacists
Jonathan Freeman Scholar – Society for Healthcare Epidemiology of America